產品詳情
簡單介紹：
Anti-KIF26B抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-KIF26B抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-KIF26B
Cat. Number:
Anti-KIF26B抗體KL-17054R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The kinesins constitute a large family of microtubule-dependent motor proteins, which are responsible for the distributionAnti-KIF26B抗體 of numerous organelles, vesicles and macromolecular complexes throughout the cell. Individual kinesin members play crucial roles in cell division, intracellular transport and membrane trafficking events including endocytosis and transcytosis. KIF26B (kinesin family member 26B) is a 2,108 amino acid protein that contains one kinesin-motor domain and belongs to the kinesin-like protein family. The kinesin-motor domain is responsible for the ATP-dependent movement of KIF26B across microtubules. KIF26B regulates the adhesion of mesenchymal cells in contact with ureteric buds, making it essential for kidney development. KIF26B is also thought to play a role in embryogenesis, specifically in the development of limbs, face and somites. KIF26B localizes to the cytoplasm and exists as two alternatively splices isoforms. The gene encoding KIF26B is located on human chromosome 1q43.
Also known as:
FLJ10157; FLJ10157;Anti-KIF26B抗體 KI26B_HUMAN; KIF26B; Kinesin-like protein KIF26B.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH Anti-KIF26B抗體conjugated synthetic peptide derived from human KIF26B.
●
Predicted Molecular Weight: 224kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-KIF26B抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-KIF26B抗體
Optimal working dilutions must be determined by the end user.
